Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
These recommendations are based on formal stability studies submitted to regulators
Patients who increase doses more gradually tend to experience milder digestive symptoms
Physical Side Effects Common side effects of GLP-1-based treatments include nausea, vomiting, and mild gastrointestinal discomfort, which usually diminish over time as the body adjusts to the medication
Electrolyte balance shifts when you are in significant caloric restriction
Some Aetna insurance plans may cover GLP-1 drugs that are FDA-approved for obesity treatment